DUBLIN--(BUSINESS WIRE)--The "Analyzing the Global Market for Active Pharmaceutical Ingredients 2018" report has been added to ResearchAndMarkets.com's offering.
The global market for active pharmaceutical ingredients (API) has been growing steadily in recent years. Though the economic recession of 2008-2009 affected the growth of the market, nevertheless, the market has bounced back with strong growth since then. However, the industry is today facing a record number of blockbuster drugs going off patent. This is having a major impact on the global API industry as revenues of the API markets are being affected as generic drugs have started to make their presence felt on the market.
The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and few upcoming patent expiries of blockbuster drugs.
An analysis of the major industry players such as Teva, Albemarle, Allergan, Boehringer, Cipla and others is carried out through an analysis of their business profile, major products & services, and a SWOT analysis. This in-depth report on the Global Market for Active Pharmaceutical Ingredients 2018 is a comprehensive profile of this industry.
Key Topics Covered:
A. Executive Summary
B. Introduction to Active Pharmaceutical Ingredients
C. Global Market for Active Pharmaceutical Ingredients (APIs)
D. Impacts on the Global API Market
E. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific
F. Market for Active Pharmaceutical Ingredients (APIs) in China
G. Market for Active Pharmaceutical Ingredients (APIs) in India
H. Market for Active Pharmaceutical Ingredients (APIs) in Japan
I. Market for Active Pharmaceutical Ingredients (APIs) in South Korea
J. Market for Active Pharmaceutical Ingredients (APIs) in Europe
K. Market for Active Pharmaceutical Ingredients (APIs) in France
L. Market for Active Pharmaceutical Ingredients (APIs) in Germany
M. Market for Active Pharmaceutical Ingredients (APIs) in Italy
N. Market for Active Pharmaceutical Ingredients (APIs) in Spain
O. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom
P. Market for Active Pharmaceutical Ingredients (APIs) in North America
Q. Market for Active Pharmaceutical Ingredients (APIs) in Canada
R. Market for Active Pharmaceutical Ingredients (APIs) in the US
S. Major Industry Players
- Albemarle Corporation
- Allergan Plc
- Ampac Fine Chemicals LLC
- Aptuit, Inc
- Aurobindo Pharma
- BASF SE
- Biocon Limited
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Company
- Cambrex Corporation
- Cipla Limited
- Dishman Pharmaceuticals & Chemicals Ltd.
- Dr. Reddy's Laboratories Limited
- Fabbrica Italiana Sintetici
- Koninklijke DSM N.V.
- Lonza Group AG
- Lupin Limited
- Medtronic Plc
- Mylan Inc
- Novartis AG
- Novasep Holding
- Pfizer Inc
- Ranbaxy Laboratories
- Sigma-Aldrich Corporation
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited
- WuXi AppTec, Inc
For more information about this report visit https://www.researchandmarkets.com/research/qkslgz/analyzing_the?w=4
